Ameliorative role of atorvastatin on methionine-induced hyperhomocysteinemia and hematological changes in albino rats

Indian Journal of Experimental Biology

Volumn 49, Issue 2, 2011, Pages 132-139

  Bhandari, Uma ^a   Pathan, Rahila Ahmad ^a   Kumar, Vinay ^a   Khanna, Naresh ^b  

^a HAMDARD UNIVERSITY   (India)

^b UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Atorvastatin; Hyperhomocysteinemia; Lipid profile; Methionine

Indexed keywords

ATORVASTATIN; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; METHIONINE; PYRROLE DERIVATIVE;

ALBINISM; ANIMAL; ARTICLE; BLOOD; BLOOD EXAMINATION; CHEMICALLY INDUCED DISORDER; DRUG SCREENING; FEMALE; HYPERHOMOCYSTEINEMIA; MALE; PATHOLOGY; RAT; RAT STRAIN; WISTAR RAT;

ALBINISM; ANIMALS; ANTICHOLESTEREMIC AGENTS; DRUG EVALUATION, PRECLINICAL; FEMALE; HEMATOLOGIC TESTS; HEPTANOIC ACIDS; HYPERHOMOCYSTEINEMIA; MALE; METHIONINE; PYRROLES; RATS; RATS, MUTANT STRAINS; RATS, WISTAR;

RATTUS;

EID: 79551621529     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Ueland P M & Refsum H, Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease and drug therapy, J Lab Clin Med, 114 (1989) 473.
2. Hankey G J & Eikelboom JW, Homocysteine and vascular disease, Lancet, 354 (1999) 407.
3. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S & Fowler B, Hyperhomocysteinemia: an independent risk factor for vascular disease, N Eng J Med, 324 (1991) 1149.
4. den Heijer M, Koster T & Blom H J, Hyperhomocysteinemia as a risk factor for deep-vein thrombosis, N Engl J Med, 334 (1996) 759.
5. Nehler M R, Taylor L M & Porter J M, Homocysteinemia as a risk factor for atherosclerosis: A review, Cardiovasc Surg, 5 (1997) 559.
6. Woo C W H, Siow Y L, Pierce G N, Choy P C, Minuk G Y & Mumin D O K, Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors, Am J Physiol Endocrinol Metab, 288 (2005) E1002.
7. Morita H, Kurihara H, Yoshida S, Saito Y, Shindo T & Oh- Hashi Y, Diet-induced hyperhomocysteinemia exacerbates neointima formation in rat carotid arteries after balloon injury, Circulation, 103 (2001) 133.
8. Kapoor P, Ansari M N & Bhandari U, Modulatory effect of curcumin on methionine-induced hypelipidemia and hyperhomocystenemia in albino rats, Indian J Exp Biol, 46 (2008) 534.
9. Hennig B, Toborek M, Alvarado C A & Decker E, Nutrition, endothelial cell metabolism, and atherosclerosis, Crit Rev Food Sci Nutr, 34 (1993) 253.
10. Klavins J V & Kinney T D, Histopathologic changes in methionine excess, Arch Pathol, 75 (1963) 661.
11. Benevenga N J & Steele R D, Adverse effects of excessive consumption of amino acids, Ann Rev Nutr, 4 (1984) 157.
12. Bath P M, Gladwin A M & Martin J F, Human monocyte Characteristics are altered in hypercholesterolemia, Atherosclerosis, 90 (1991) 175.
13. Rasouli M, Kiasari A M & Bagheri B, Total and differential leukocytes counts, but not hsCRP, ESR, and five fractioned serum proteins have significant potency to predict stable coronary artery disease, Clin Chim Acta, 377 (2007) 127.
14. Durand P, Lussiercacan C S & Biache D, Acute methionine load-induced Hhcy enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats, FASEB J, 11 (1997) 1157.
15. National Institute of Neurological Disorders and Stroke (NINDS) Clinical Trial.gov Identifier: NCT00293748, Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease, Feb 2006.
16. Stalker T J, Lefer AM & Scalia R, A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: The role of mevalonic acid, Br J Pharmacol, 133 (2001) 406.
17. Ikeda Y, Young L H, Lefer A M, Rosuvastatin, a new HMGCoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats, J Cardiovasc Pharmacol, 41 (2003) 649.
18. Bickel C, Rupprecht H J, Rippin G, Hafner G, Treude R & Othman H, Relation of markers of inflammation and statin therapy to long term mortality in patients with angiographically proven coronary artery disease, Am J Cardiol, 89 (2002) 901.
19. Lüftjohann D, Sigit J I, Locatelli S, von Bergmann K & Schmidt H H A, High-dose simvastatin (80 mg/day) decreases plasma concentrations of total homocysteine in patients with hypercholesterolemia, Atherosclerosis, 155 (2001) 265.
20. Millionis H J, Papakostas J, Kakafika A, Chasiotis G, Seferiadis K & Elisaf M S, Comparative effects of atorvastatin, simvastatin and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia, J Clin Pharmacol, 43 (2003) 825.
21. Schroecksnadel K, Frick B, Winkler C, Wirleitner B, Weiss G & Fuchs D, Atorvastatin suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells, Clin Chem Lab Med, 43 (2005) 1373.
22. Giral P, Giral E, Jacob N, Chapman M J, Foglietti M J & Turpin G, Homocysteine and lipid lowering agents: A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia, Atherosclerosis, 154 (2001) 421.
23. Malik J, Melenovsky V, Wichterle D, Haas T, Simek J & Ceska R, Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial-FAT), Cardiovasc Res, 52 (2001) 290.
24. Ansari M N, Nigam G K & Bhandari U, Effect of Folic Acid on Hematological Changes in Methionine-Induced Hyperhomocysteinemia in Rats, Indian J Pharm Sci, 71 (2009) 270.
25. Bhandari U, Ansari MN, Islam F & Tripathi CD, The effect of aqueous extract of Embelia ribes Burm on serum homocysteine, lipids and oxidative enzymes in methionine induced hyperhomocysteinemia, Indian J Pharmacol, 40 (2008) 152.
26. Amin KA & Abd El-Twab TM, Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats: role of atorvastatin and cinnamon, Int J Clin Exp Med, 2 (2009) 254.
27. AL-Rawi M M & Maisaa M, Efficacy of oat bran (Avena sativa L.) in comparison with atorvastatin in treatment of hypercholesterolemia in albino rat liver, The Egyptian J. of Hospital Med, 29 (2007) 511.
28. Primus F J, Kelley E A, Hansen H J & Goldenberg D M, Sandwich-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy, Clin Chem, 34 (1998) 261.
29. Burstein M, Scholnick M R & Morfin R, Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions, J Lipid Res, 11(1970) 583.
30. Demacher P N M & Hijamaus A G M, A study of the use of polyethylene glycol in estimating cholesterol, Clin Chem, 26 (1980) 1775.
31. Foster L B & Dunn R T, Stable reagents for the determination of serum triglycerides by a colorimetric Hantzch condensation method, J Clin Chem, 19 (1973) 338.
32. Dacie J V & Lewis S M, Practical hematology, 9th ed (Churchill Livingstone, London) 2001, 19.
33. Wesch G N & Loscalzo J, Homocysteine and atherosclerosis, N Engl J Med, 338 (1998) 1042.
34. McCully K S, Homocysteine and vascular disease, Nat Med, 2 (1996) 386.
35. Eikelboom J W, Lonn E, Genest J, Hankey G & Yusuf S, Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence, Ann Intern Med, 131 (1999) 363.
36. Fuhrman B, Koren L, Volkova N, Keidar S, Hayek T & Aviram M, Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes, Atherosclerosis, 164 (2002) 179.
37. Davidson M H, Clinical significance of statin pleiotropic effects: hypotheses versus evidence, Circulation, 111 (2005) 2280.
38. Shanes J G, Minadeo K N, Moret A, Groner M & Tabaie S A, Statin therapy in heart failure: Prognostic effects and potential mechanisms, Am Heart J, 154 (2007) 617.
39. Guttormsen A B, Schneede J, Fiskerstrand T, Ueland P M & Refsum H M, Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects, J Nutr, 124 (1994) 1934.
40. Kapoor H K, Bhai S, John M & Xavier J, Ocular manifestations of dengue fever in an East Indian epidemic, Can J Ophthalmol, 41 (2006) 741.
41. Zulli A, Buxton B, Doolan L & Liu J J, Effect of homocysteine and cholesterol in raising plasma homocysteine, cholesterol and triglyceride levels, Life Sci, 62 (1998) 2191.
42. Martinez L O, Jacquet S, Terce F, Collet X, Perret B & Barbaras R, New insight on the molecular mechanisms of high-density lipoprotein cellular interactions, Cell Mol Life Sci, 61 (2004) 2343.
43. Mehta K, Balaraman R, Amin A H, Bafna PA & Gulati O D, Effect of fruits of Moringa oleifera on the lipid profile of normal and hypercholesterolaemic rabbits, J Ethnopharmacol, 86 (2003) 191.
44. Lee C D, Folsom A R, Nieto F J, Chambless L E, Shahar E & Wolfe D A, White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study, Am J Epidemiol, 154 (2001) 758.
45. Lentz S R, Homocysteine and vascular dysfunction, Life Sci, 61 (1997) 1205.
46. Ali A, Mehra M R & Lavie C J, Modulatory impact of cardiac rehabilitation on hyperhomocysteinemia in patients with coronary artery disease and "normal" lipid levels, Am J Cardiol, 82 (1998) 1543.
47. Lavie C J, Milani R V & O'Keefe JH. Update on new coronary risk factors (editorial), Chest, 110 (1996) 583.
48. Dudman N P, Temple S E, Guo X W, Fu W & Perry M A, Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo, Circ Res, 84 (1999) 409.